Patient Considerations in the Treatment of COPD: Focus on the New Combination Inhaler Umeclidinium/Vilanterol

Patient Preference and Adherence- New Zealand

doi 10.2147/ppa.s71535

Full Text

Abstract

Available in

Date

Authors

Publisher

Informa UK Limited

Related search

Evidence-Based Review of Data on the Combination Inhaler Umeclidinium/Vilanterol in Patients With COPD

International Journal of COPD
EnvironmentalPublic HealthHealth PolicyMedicinePulmonaryRespiratory MedicineOccupational Health
2019English

Single-Inhaler Triple Therapy Utilizing the Once-Daily Combination of Fluticasone Furoate, Umeclidinium and Vilanterol in the Management of COPD: The Current Evidence Base and Future Prospects

Therapeutic Advances in Respiratory Disease
PulmonaryRespiratory MedicinePharmacology
2018English

Reduction in All-Cause Mortality With Fluticasone Furoate/Umeclidinium/Vilanterol in COPD Patients

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2020English

Patient Considerations in the Management of Chronic Constipation: Focus on Prucalopride

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2016English

P275 Comparing Clinically Relevant Improvement With Umeclidinium/Vilanterol and Tiotropium/Olodaterol in Symptomatic Copd: A Randomised Non-Inferiority Crossover Trial

2017English

The Knowledge and Considerations of the Physicians Regarding the Inhaler Devices in Asthma and COPD: The INTEDA-1 Study

Tuberkuloz ve Toraks
PulmonaryCritical CareRespiratory MedicineSurgeryIntensive Care Medicine
2013English

Prs17 - Budget Impact Analysis of the Use of Umeclidinium Bromide/Vilanterol 62.5/25 MCG in the Treatment of Chronic Obstructive Pulmonary Disease in Spain

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pharmacokinetics and Tolerability of Inhaled Umeclidinium and Vilanterol Alone and in Combination in Healthy Chinese Subjects: A Randomized, Open-Label, Crossover Trial

PLoS ONE
Multidisciplinary
2015English

Salmeterol Plus Theophylline Combination Therapy in the Treatment of COPD

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy